Melaleuca, Inc. v. Clark

78 Cal. Rptr. 2d 627, 66 Cal. App. 4th 1344, 98 Cal. Daily Op. Serv. 7525, 98 Daily Journal DAR 10421, 1998 Cal. App. LEXIS 819
CourtCalifornia Court of Appeal
DecidedSeptember 29, 1998
DocketD028639, D029533
StatusPublished
Cited by45 cases

This text of 78 Cal. Rptr. 2d 627 (Melaleuca, Inc. v. Clark) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Melaleuca, Inc. v. Clark, 78 Cal. Rptr. 2d 627, 66 Cal. App. 4th 1344, 98 Cal. Daily Op. Serv. 7525, 98 Daily Journal DAR 10421, 1998 Cal. App. LEXIS 819 (Cal. Ct. App. 1998).

Opinion

Opinion

BENKE, J.

If this appeal turned solely on the question of whether statements defendant and appellant Huida Regehr Clark has published about products distributed by plaintiff and respondent Melaleuca, Inc. (Melaleuca), are true, there is little doubt Melaleuca would prevail. There is simply no scientific basis for Clark’s conclusions about Melaleuca’s products, and the acceptable scientific evidence which is in the record entirely refutes Clark’s conclusions.

However, the law of defamation and the law of injurious falsehood require that a plaintiff prove far more than the publication of a false statement. Where, as here, the defendant has made false statements which disparage the contents of a product, the owner or distributor of the product is required to produce clear and convincing evidence the defendant acted with actual malice. A statement is made with actual malice when the publisher either knows the statement is false or has some serious subjective doubt about the truth of the statement.

Here the trial court erred in giving an instruction which permitted the jury to find actual malice on an objective basis. Because the jury found that Clark did not know her statements were false and because the record with respect to any doubts she had was in sharp conflict, the instruction prejudiced Clark. Accordingly, we reverse the judgment entered in favor of Melaleuca and vacate the postjudgment orders it entered.

Factual and Procedural Background

Melaleuca is in the business of selling a line of personal hygiene, cosmetic, household cleaning, over-the-counter pharmaceutical, nutrition and *1351 pet care products. Most of the 110 products it markets contain tea tree oil derived from leaves of the melaleuca altemifolia, a tree which grows primarily in the Australian province of New South Wales.

Melaleuca’s products are designed to meet a demand for natural products which are safe and effective. The company markets its products exclusively through a biannual catalog and a network of 170,000 independent marketing executives who sell Melaleuca products on a part-time basis as a supplement to their household income. Melaleuca does not advertise in print or electronic media but instead relies upon word of mouth and its sales network. In 1996 Melaleuca experienced gross monthly sales of between $3.5 million and $4.5 million.

Clark is an independent research scientist who operates a diagnostic center near Tijuana, Mexico. Clark claims to have discovered the cause and have a cure for all cancers, HIV/AIDS and a number of other serious illnesses. Briefly, Clark believes all cancers and many diseases are caused by existence of intestinal parasites and toxic substances in a person’s body. Clark believes once an individual stops being exposed to the toxic substances, in particular, isopropyl alcohol and benzene, the individual’s health will improve because the individual’s immune system will be better able to resist the parasites which she believes are the direct cause of disease.

Clark claims she has been able to develop a device, a “syncrometer,” which is capable of detecting the presence of carcinogenic chemicals, such as benzene, to one part per quadrillion. According to Clark, she can use the syncrometer to both test for the presence of benzene in particular products and in individual patients.

In two books she has published (The Cure for All Cancers (1993), and The Cure for HIV and AIDS (1993)), Clark states she has found benzene in a number of household products and foods, including Melaleuca’s products. In a third book, The Cure for All Diseases (1995), Clark states she has found benzene in all tea tree oil products, except one product which is not marketed by Melaleuca. The three books Clark published had gross sales in excess of $7 million.

Melaleuca first learned of Clark’s statements about its products in late 1994. In response, Melaleuca retained an independent laboratory to conduct tests of its product. The laboratory could not find any benzene in Melaleuca’s products.

In March 1995, following receipt of the laboratory’s report, Melaleuca sent Clark a letter in which it demanded she stop distributing her books. She *1352 did not respond to Melaleuca’s demand and in June 1995 Melaleuca sued Clark for libel, defamation, trade libel, negligence, negligent interference with prospective economic advantage, intentional interference with contractual relations and injunctive relief.

At trial Melaleuca moved in limine to prevent Clark from attempting to establish the truth of her statements by relying on syncrometer testing. In support of its motion, Melaleuca presented testimony from a chemist. The expert, using conventional gas chromatography and mass spectroscopy, could not find any benzene in the Melaleuca products he tested. Gas chromatography which separates components in a mixture and mass spectroscopy which identifies the components, can detect the presence of a chemical to 10 parts per million. The chemist further testified there was no accepted scientific basis for the syncrometer testing advocated by Clark in her books.

After hearing extensive testimony on the issue, the trial court granted Melaleuca’s motion. The trial court determined Clark’s syncrometer testing was not an accepted scientific procedure and that she could not use it to establish the existence of benzene in Melaleuca’s products. However, the trial court did permit Clark to present evidence that she used the syncrometer in order to establish her state of mind at the time she published her books.

The trial court found that although Melaleuca was not a public figure, Clark’s statements about its products were a matter of public concern. Accordingly, as a predicate to recovery of presumed and punitive damages, the trial court required that Melaleuca show that Clark either knew her statements were false or made them with reckless disregard of their falsity. In instructing the jury on Clark’s state of mind, the trial court gave a modified version of BAJI No. 7.04.1 which, among other matters, defines reckless disregard of falsity in terms of whether the defendant “must have had serious doubts about the truthfulness of the statement at the time of the publication.” (Italics added.) The jury returned a verdict in favor of Melaleuca on its defamation and interference with economic advantage claims.

The jury found Clark’s statements were false, that although Clark did not know they were false, she nonetheless published the statements in reckless disregard of whether they were false. The jury also found Clark’s statements interfered with Melaleuca’s relationship with its marketing executives. In addition to these findings, the jury found Clark acted with the oppression, fraud and malice required to support an award of punitive damages under Civil Code section 3294.

On the defamation claims the jury awarded Melaleuca a total of $6,000 in special damages and $178,000 in presumed damages. With respect to the *1353 economic interference .claims the jury found that Melaleuca suffered an additional $366,000 in compensatory damages. In addition to the compensatory damages the jury awarded Melaleuca $1 million in punitive damages.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Mahoney v. Huang CA1/1
California Court of Appeal, 2025
Heitkoetter v. Domm
E.D. California, 2024
Gopher Media LLC v. Melone
S.D. California, 2023
Young v. Schultz CA1/3
California Court of Appeal, 2023
ZF Micro Solutions v. Tat Capital Partners CA4/3
California Court of Appeal, 2022
Prehired, LLC v. Provins
E.D. California, 2022
Dog & Rooster v. Green CA4/1
California Court of Appeal, 2021
Medical Marijuana, Inc. v. ProjectCBD.com
California Court of Appeal, 2020
Peak Health Center v. Dorfman
N.D. California, 2020
Sonoma Media Investments, LLC v. Superior Court
California Court of Appeal, 2019
Sonoma Media Invs., LLC v. Superior Court of Sonoma Cnty.
246 Cal. Rptr. 3d 1 (California Court of Appeals, 5th District, 2019)
Elec. Frontier Found. v. Global Equity Mgmt. (SA) Pty Ltd.
290 F. Supp. 3d 923 (N.D. California, 2017)
ZL Technologies v. Doe
California Court of Appeal, 2017
ZL Techs., Inc. v. Doe
220 Cal. Rptr. 3d 569 (California Court of Appeals, 5th District, 2017)
Underground Solutions, Inc. v. Palermo
188 F. Supp. 3d 717 (N.D. Illinois, 2016)
J-M Manufacturing Co. v. Phillips & Cohen LLP
247 Cal. App. 4th 87 (California Court of Appeal, 2016)
LifeVantage Corp. v. MacFarland CA1/15
California Court of Appeal, 2015
Song Fi Inc. v. Google, Inc.
108 F. Supp. 3d 876 (N.D. California, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
78 Cal. Rptr. 2d 627, 66 Cal. App. 4th 1344, 98 Cal. Daily Op. Serv. 7525, 98 Daily Journal DAR 10421, 1998 Cal. App. LEXIS 819, Counsel Stack Legal Research, https://law.counselstack.com/opinion/melaleuca-inc-v-clark-calctapp-1998.